Materialise (NSDQ:MTLS) said today it inked a distribution deal with Canon (NYSE:CAJ) Lifecare Solutions to distribute its Materialise Mimics Innovation software and care suits in Japan. Through the agreement, workstations and 3D printers offered by Canon Lifecare Solutions will be offered with Materialise’s open software solutions, including the newly launched Materialise Mimics inPrint designed to allow hospitals to […]
Imaging
St. Jude expands EnSite Precision launch in EU, seeks FDA approval
St. Jude Medical (NYSE:STJ) said today it is expanding its commercial release of its EnSite Precision cardiac mapping system in the European Union, and that it is currently pursuing FDA clearance of the system. The St. Paul, Minn.-based company’s Ensite cardiac mapping system is designed for use in ablation procedures to visualize and aid in catheter […]
Varian backs Phase III non-small cell lung cancer trial
Varian Medical (NYSE:VAR) said today it is supporting a Phase III clinical trial set to compare outcomes of radiosurgery against surgical resection for treating early-stage, high-risk operable non-small cell lung cancer. The randomized “Stablemates Trial” will test the hypothesis that 3-year overall survival in high risk operable patients with Stage I NSCLC is equivalent or greater in […]
IsoRay spikes GliaSite radiation therapy device
IsoRay (NYSE:ISR) said yesterday that it’s spiking its GliaSite radiation therapy system for treating brain cancers, after achieving only modest sales since the FDA cleared the device in 2011. Richland, Wash.-based IsoRay said it’s cancelling its deals with Dr. Reddy’s Laboratories (NYSE:RDY), Hologic (NSDQ:HOLX) and Karlheinz Goehl-Medizintechnik Goehl concerning GliaSite. “The GliaSite product has resulted in only marginal […]
Toshiba partners with UCI to study potential brain damage in HS football players
Toshiba (TYO:6502) said yesterday it is partnering with the University of California, Irvine to study possible brain damage incurred in high school football players. The study is the 1st-of-its-kind investigating cerebral microbleeds as a potential precursor to chronic traumatic encephalopathy, and will operate using Toshiba’s Vantage Titan 3T magnetic resonance imager as the main diagnostic tool, […]
Eos Imaging wins FDA nod for spineEos 3D planning solution
EOS Imaging (EPA:EOSI) said it won pre-market approval from the FDA for its spineEos 3D planning software for spinal surgeries. Paris-based Eos won CE Mark approval in the European Union in February for the system, which is designed to use 3D imaging to create optimized treatment plans for pediatric patients with scoliosis and adults with […]
Profound Medical wins CE Mark for Tulsa-Pro ablation device
Profound Medical said today it won CE Mark approval in the European Union for its Tulsa-Pro ablation device designed to treat prostate cancer. The Toronto-based company’s system allows for a minimally invasive, whole-gland ablation of the prostate, guided by magnetic resonance imaging machines, the company said. “Our innovation and passion for this unique therapy has […]
Mach7 Technologies closes $60m merger with 3D Medical
Mach7 Technologies said today that it closed its $60 merger with 3D Medical (ASX:3DM), saying it will begin trading on the Australian Stock Exchange under the “M7T” symbol. The deal unites Mach7’s enterprise image management offerings with 3D Medical’s medical 3D printing. “Our commitment to customer-driven design remains the core of our culture and the soul of our […]
Mauna Kea inks research collab deal with EM Imaging
Mauna Kea (ENT:MKEA) said yesterday it inked a research collaboration deal with Edinburgh Molecular Imaging to explore the combination of EM Imaging’s in vivo optical imaging agents with Mauna Kea’s confocal laser endomicroscopy platform to diagnose cancer. EM Imaging said it will supply optical imaging agent EMI-137 to 2 investigational sites to perform clinical efficacy studies […]
Toshiba wins clearance from USAF for Aplio Platinum ultrasound systems
Toshiba (TYO:6502) said today it won clearance through an “authorization to operate” with the U.S. Air Force for the company’s Aplio Platinum series of ultrasound systems. Toshiba’s Aplio 500 platinum and Aplio 300 platinum ultrasound systems won clearance by meeting the Air Force and Defense Health Agency’s Platform Information Technolagy guidelines implemented to protect Patient Health Information […]
Navidea to seek rheumatoid arthritis indication for Lymphoseek
Navidea (NYSE:NAVB) said today it is beginning the clinical trial development process as it seeks an indication for its Lymphoseek injection for treating rheumatoid arthritis and other disease states. The decision came after a recent meeting with the FDA, the Dublin, Ohio-based company said. “Our efforts to continue to unlock the significant value of the Manocept platform […]